How HIV Infects Lymphocytes
- HIV targets helper T-cells, a type of lymphocyte critical for coordinating immune responses.
- The virus binds to the CD4 receptor on the surface of these cells, allowing it to enter.
- Inside the cell, HIV uses an enzyme called reverse transcriptase to convert its RNA into DNA.
- This viral DNA integrates into the host cell’s genome, turning the cell into a factory for producing new viruses. viral DNA integrates into the host cell’s genome, turning the cell into a factory for producing new viruses.

HIV is a retrovirus, meaning it carries its genetic material as RNA instead of DNA.
The Role of Helper T-Cells in Immunity
- Helper T-cells are essential for activating other immune cells, such as:
- B-lymphocytes: These cells produce antibodies that neutralize pathogens.
- Cytotoxic T-cells: These cells destroy infected or cancerous cells.
- Without helper T-cells, the immune system cannot effectively coordinate these responses.
Remember: Helper T-cells act like the "managers" of the immune system, directing other cells to perform their tasks.
The Progression from HIV to AIDS
- Initial Infection: After exposure, HIV rapidly multiplies, causing flu-like symptoms. During this stage, the immune system produces antibodies against the virus.
- Latency Period: The virus remains active but hidden, gradually destroying helper T-cells. This phase can last for years without noticeable symptoms.
- AIDS: When the number of helper T-cells (Also called CD4 cells) falls below a critical level, the immune system becomes severely compromised. This stage is characterized by:
- Opportunistic Infections: Diseases like tuberculosis, pneumonia, and certain cancers that a healthy immune system would typically control.
- Marker Diseases: Conditions like Kaposi’s sarcoma, a rare cancer, which are often used to diagnose AIDS.
- Final stage: AIDS (Acquired Immunodeficiency Syndrome) is diagnosed when the helper T-cell count drops below 200 cells/mm³ (normal range: 500–1,500 cells/mm³) or when the patient develops severe opportunistic infections or cancers.



